SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: NNVC - NanoViricides, Inc.

24 Oct 2017 02:14 PM
28 Nov 2015 02:53 PM
18 Nov 2015 01:29 PM
17 Nov 2015 03:49 PM
16 Mar 2015 09:49 AM <--
11 Mar 2015 09:41 PM
05 Mar 2015 03:34 PM
22 Jan 2015 09:17 AM
22 Dec 2014 09:14 PM
28 Nov 2014 02:19 PM
16 Nov 2014 10:38 AM
05 Nov 2014 08:44 AM
01 Nov 2014 01:50 PM
27 Aug 2014 09:44 PM
27 Aug 2014 06:47 PM
25 Aug 2014 02:08 PM
11 Mar 2014 01:40 PM
28 Feb 2014 09:47 PM
07 Oct 2013 10:26 AM
06 Oct 2013 12:36 PM
05 Oct 2013 03:15 PM
23 Sep 2013 10:54 AM
06 Sep 2013 03:55 PM
04 Sep 2012 08:54 AM
10 May 2012 04:05 PM
10 May 2012 03:59 PM
09 May 2012 09:24 AM
08 May 2012 08:41 AM
07 May 2012 08:11 AM
15 Nov 2011 08:35 PM
15 Nov 2011 08:35 PM
26 Oct 2011 11:54 AM
20 Jul 2011 01:48 PM
16 Jul 2011 10:59 AM
16 Jul 2011 10:56 AM
22 Jan 2008 10:02 AM
15 Feb 2007 08:13 AM
15 Nov 2006 11:45 AM
21 Oct 2006 09:02 AM
20 Oct 2006 04:18 PM
23 Sep 2006 12:43 PM
02 Aug 2006 01:46 PM
27 May 2006 09:55 AM
22 May 2006 09:29 AM
01 May 2006 05:45 PM
23 Mar 2006 11:27 AM
18 Jan 2006 09:44 PM
11 Jan 2006 04:41 PM
08 Jan 2006 12:31 AM
04 Jan 2006 03:44 PM
25 Nov 2005 10:35 AM
24 Nov 2005 01:22 PM
23 Nov 2005 07:20 PM
17 Nov 2005 05:12 PM
03 Oct 2005 01:59 PM
30 Sep 2005 05:01 PM
04 Aug 2005 07:57 PM
13 Jul 2005 11:11 AM

Return to NNVC - NanoViricides, Inc.
 
THIS IS A BULLS BOARDS - If not bullish - post it elsewhere!

New lab -
Shelton CT

EbolaCide2 - Plan of attack

Re: USAMRIID
Corinne (Scully) is gone and Gene (Olinger) is at the NIH virology labs
I'm in touch with Gene and would love to work with him.
We're shooting for a mid-November ship date but that's completely dependent on completing the synthesis of all the variants. Usually we make 8 variants, send them for testing, take the best two, expand them and make another eight.
This time, we're making many more and they'll all be tested during the same pass to save time.
If this works as we hope, I want to get EbolaCide to Africa ASAP!

EUGENE SEYMOUR - Chief Executive Officer & Director
October 31, 2014

Lab Facilities:
Present -
bench top model:


New lab - walk-in hood about 10 feet high:


Dr. Diwan, President NNVC and inventor explains the underlying newly patented technology and other NNVC licensed patent applications


NanoViricides, Inc. (NNVC)
A typical nanoviricides drug is designed like a chemical missile. It has a number of recognition "ligands" on its surface, that are specific to a single type of virus, say HIV. They are like the GPS on a directed missile. They will identify the enemy and attach to specific "landing sites" on the enemy target. The nanoviricides drug, after landing, spreads itself all over the virus particle, and thus completely neutralizes and disables the virus particle from binding to its target, a human cell.

NanoViricides CEO's Letter to Shareholders, March 11, 2014

Officers and Executives
Dr. Anil R. Diwan
Chairman, President & Secretary
Ms. Meeta R. Vyas
Chief Financial Officer
Dr. Randall W. Barton
Chief Scientific Officer
Dr. Jayant Tatake
Vice President-Research & Development
Dr. Milton Boniuk
Independent Director
Dr. Eugene Seymour
Chief Executive Officer & Director
Mr. Stanley Glick
Independent Director
Dr. Mukund S. Kulkarni
Independent Director
Dr. Krishna Kumar Menon
Chief Regulatory Officer


IP
Solubilization and Targeted Delivery of Drugs with Selfassembling Amphiphilic PolymersOral administration
Antibody response with Oral administration was stronger than that with IV administration.

Internet Information
Home Page: nanoviricides.com
Investor Relations: nanoviricides.com
Corporate History/Profile: nanoviricides.com
Executives: nanoviricides.com
Products/Services: nanoviricides.com

NanoViricides Inc Group Headquarters: SUITE 205, 135 WOOD STREET, WEST HAVEN, CT 06516, United States

Potential competitors
Vecoy Nanomedicines Ltd.
Tekmira
Inovio

Toxicology Evaluation
NanoViricides Announces Initiation of Toxicology Study of FluCide®